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ABSTRACT 
 
Background: Cervical cancer ranked fourth against most women's cancer 
worldwide. The incidence of cervical cancer was estimated at 528,000 (7.9%) 
cases in the world causing 266,000 deaths in 2012. Cervical cancer is caused by a 
human papilloma-virus (HPV). The HPV vaccine can protect women from HPV 
infection, thus lowering the risk of cervical cancer. This study aimed to examine 
the factors associated with the use of HPV vaccination in women of reproductive 
age, using Health Belief Model. 
Subjects and Method: This was a case-control study conducted at Permata 
Harapan Oncology Clinic, Surakarta, from January to February 2018. A total 
study of 200 women of reproductive age was selected by fixed disease sampling. 
The dependent variable was the use of HPV vaccination. The independent 
variables were knowledge, perceived seriousness, perceived susceptibility, 
perceived barrier, perceived benefit, family income, and family support. The data 
were collected by questionnaire and analyzed by a multiple logistic regression.  
Results: The use of HPV vaccination increased with better knowledge (OR= 
7.97; 95% CI= 1.50 to 42.38; p= 0.015), perceived seriousness (OR= 22.81; 95% 
CI= 6.06 to 85.86; p<0.001), perceived susceptibility (OR=4.03; 95%CI= 1.25 to 
13.09; p=0.020), perceived benefit (OR= 6.57; 95% CI= 1.88 to 22.98; p=0.003), 
family income (OR= 5.32; 95% CI= 1.57 to 18.07; p=0.007), and family support 
(OR= 6.86; 95% CI= 1.55 to 30.36; p=0.011). The use of HPV vaccination 
decreased with perceived barrier (OR= 0.14; 95% CI= 0.04 to 0.51; p=0.003). 
Conclusion: HPV vaccination increases with better knowledge, perceived 
seriousness, perceived susceptibility, perceived benefit, family income, and family 
support, but decreases with perceived barrier. 
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